Editorial: Complex network dynamics of cognitive processing in health and disease: current knowledge and future research

Authors:

Abstract
(Faskowitz et al., 2020;Novelli and Razi, 2022;Finc et al., 2026). Advances in neuroimaging and electrophysiology-including EEG, fMRI, MEG, PET, and multimodal combinationshave enabled researchers to characterize brain-network organization across complementary spatial and temporal scales, although each modality captures only part of the underlying dynamics (Lake and Higley, 2022). The evidence spans millisecond EEG states, moment-tomoment fMRI co-fluctuations, multimodal disease-network mapping, motor preparation, and neuroimmune/genomic interactions. The strongest convergence is that disease or increased cognitive demand changes network state transitions, not just regional activity. Simultaneously, advanced computational methods such as graph theory and machine learning offer new frameworks for understanding brain connectivity complexity (Mohammadi and Karwowski, 2024;Yang et al., 2025). Two contributions in this collection demonstrate that EEG microstates -brief, quasi-stable patterns of global scalp electrical activity lasting 80-120 milliseconds -offer a uniquely sensitive window onto large-scale network dynamics (Michel et al., 2024). Across these five contributions, several cross-cutting themes emerge. First, cognitive health depends on flexibility and on coordinated integration and segregation (Barabino et al., 2024).The DMN appears as a recurring locus of disruption -in MCI, SCD, PD with ICDs, and PTSD -underscoring its centrality to self-referential processing, memory, and cognitive control across the disease spectrum (Smallwood et al., 2021;Sanz-Morales and Melero, 2024).Interestingly, network dynamics emerge as predictive and context-sensitive features. Second, methodological innovation is driving discovery: edge-centric connectivity (Novelli and Razi, 2022), microstate analysis, and FCNM each offer complementary perspectives that conventional region-of-interest or seed-based approaches cannot provide. Third, the integration of genetics, immunology, and neuroimaging signals a necessary move toward multimodal and multiscale models of cognition and disease.Looking ahead, longitudinal designs are critically required to determine whether the network signatures identified herein -including altered microstate dynamics, disrupted co-fluctuation patterns, and subcortical-cortical imbalances -precede clinical symptom onset and predict disease trajectory. Larger and more diverse cohorts will be essential to validate these biomarkers across different populations. The translation of EEG microstate and connectivity biomarkers into clinical tools -for early diagnosis, patient stratification, and treatment monitoring -represents a particularly exciting frontier (Michel et al., 2024). Finally, the integration of non-invasive brain stimulation approaches (TMS, tDCS with real-time networkstate decoding offers a pathway toward genuinely closed-loop, network-targeted interventions (Wischnewski et al., 2024;Casazza et al., 2026).

This publication has 12 references indexed in Scilit: